- Home
- PHX vs ECOR Comparison
PHX vs ECOR Comparison
Compare PHX & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHX
- ECOR
- Stock Information
- Founded
- PHX 1926
- ECOR 2005
- Country
- PHX United States
- ECOR United States
- Employees
- PHX N/A
- ECOR N/A
- Industry
- PHX Oil & Gas Production
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PHX Energy
- ECOR Health Care
- Exchange
- PHX Nasdaq
- ECOR Nasdaq
- Market Cap
- PHX 137.2M
- ECOR 111.3M
- IPO Year
- PHX N/A
- ECOR 2018
- Fundamental
- Price
- PHX $3.99
- ECOR $15.91
- Analyst Decision
- PHX Strong Buy
- ECOR Strong Buy
- Analyst Count
- PHX 2
- ECOR 1
- Target Price
- PHX $4.90
- ECOR $25.00
- AVG Volume (30 Days)
- PHX 102.2K
- ECOR 121.6K
- Earning Date
- PHX 03-11-2025
- ECOR 03-12-2025
- Dividend Yield
- PHX 4.01%
- ECOR N/A
- EPS Growth
- PHX N/A
- ECOR N/A
- EPS
- PHX 0.13
- ECOR N/A
- Revenue
- PHX $31,939,771.00
- ECOR $23,327,000.00
- Revenue This Year
- PHX $6.31
- ECOR $59.81
- Revenue Next Year
- PHX $22.61
- ECOR $38.49
- P/E Ratio
- PHX $31.06
- ECOR N/A
- Revenue Growth
- PHX N/A
- ECOR 74.10
- 52 Week Low
- PHX $2.95
- ECOR $5.32
- 52 Week High
- PHX $4.15
- ECOR $18.67
- Technical
- Relative Strength Index (RSI)
- PHX 55.14
- ECOR 53.80
- Support Level
- PHX $3.92
- ECOR $14.04
- Resistance Level
- PHX $4.02
- ECOR $16.12
- Average True Range (ATR)
- PHX 0.09
- ECOR 1.19
- MACD
- PHX -0.00
- ECOR -0.30
- Stochastic Oscillator
- PHX 42.86
- ECOR 40.39
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.